Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2008
12/23/2008CA2419067C Injectable composition comprising benzimidazole compound and strong alkali
12/18/2008WO2008154353A1 Thalidomide analogs for treating vascular abnormalities
12/18/2008WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008WO2008153857A1 Dual-acting benzoimidazole antihypertensive agents
12/18/2008WO2008153752A2 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008WO2008153701A1 Compounds for inhibiting ksp kinesin activity
12/18/2008WO2008153573A1 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
12/18/2008WO2008153325A1 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
12/18/2008WO2008153289A2 Process for preparing bepotastine and intermediates used therein
12/18/2008WO2008153091A1 Screening method
12/18/2008WO2008152753A1 Novel crystal of 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1h-benzimidazole sodium salt and process for producing the same
12/18/2008WO2008152462A1 A process of sulfoxidation of biologically active compounds
12/18/2008WO2008152223A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor
12/18/2008WO2008152093A2 Diaminopyrimidines as modulators of the ep2 receptor
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008152013A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008WO2008151584A1 Method for the preparation of high purity almotriptan
12/18/2008WO2008131000A3 7-substituted indole mcl-1 inhibitors
12/18/2008WO2008130879A3 Tetrahydroindole and tetrahydroindazole derivatives
12/18/2008WO2008130320A3 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
12/18/2008WO2008130319A3 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
12/18/2008WO2008118849A3 Hiv-1 protease inhibitors
12/18/2008WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008103574A3 Peroxisome proliferator activated receptor modulators
12/18/2008WO2008102127A3 Gel forming compounds
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008WO2008089201A3 Heterocyclic-substituted piperidine as orl-1 ligands
12/18/2008WO2008080056A3 Pyridazinones and furan-containing compounds
12/18/2008WO2008067390A3 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof
12/18/2008US20080312449 New Compounds
12/18/2008US20080312446 Imaging agents for diagnosis of parkinson's disease
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312288 Solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl]-pyridine
12/18/2008US20080312287 Compound and Methods For the Treatment of Cancer and Malaria
12/18/2008US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors
12/18/2008US20080312281 G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes
12/18/2008US20080312280 3- (4-{ [4- (4-{ [3-(3, 3-Dimethyl-1-Piperidinyl) Propyl] Oxy} Phenyl) -1-Piperidinyl] Carbonyl}-1-Naphthalenyl) Propanoic or Propenoic Acid as H1 and H3 Receptor Antagonists for the Treatment of Inflammatory and/or Allergic Disorders
12/18/2008US20080312278 Hydroxyquinoline Derivatives
12/18/2008US20080312276 4,5 Dihydro-(1H)-Pyrazole Derivatives as Cannabinoid CB1 Receptor Modulators
12/18/2008US20080312275 Novel Cyanoguanidine Compounds
12/18/2008US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity
12/18/2008US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders
12/18/2008US20080312261 4- (4-Bromo-2-Fluoroanilino) -6- Methoxy-7- (1-Methylpiperidin-4-Ylmethoxy) Quinazoline Monohydrate
12/18/2008US20080312251 Aminopyrimidine Compounds and Their Salts, Process for Preparation and Pharmaceutical Use Thereof
12/18/2008US20080312243 Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions
12/18/2008US20080312240 Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists
12/18/2008US20080312238 4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312236 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity
12/18/2008US20080312235 Pyridine Derivatives
12/18/2008US20080312234 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/18/2008US20080312232 N-(3-fluoro-4-(6-(pyrrolidine-1-carboxamido)pyridin-4-yloxy)phenyl)-1-(2-hydroxy-2-methylpropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide, used for prophylaxis and treatment of hepatocyte growth factor mediated diseases, such as cancer and angiogenesis
12/18/2008US20080312222 4-Benzyledene-Piperidin Derivatives
12/18/2008US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/18/2008US20080312213 7-Pyrazolylbenzazepines Having Affinity For D3 Receptor
12/18/2008US20080312212 Organic Compounds
12/18/2008US20080312209 Piperazine Heteroaryl Derivatives as Gpr38 Agonists
12/18/2008US20080312208 Pyridine Analogues
12/18/2008US20080312192 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases
12/18/2008US20080311079 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12/18/2008US20080311077 Antiviral Compounds
12/18/2008US20080311075 Hepatitis C Virus Inhibitors
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2694871A1 Chemical compounds
12/18/2008CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008CA2690789A1 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
12/18/2008CA2690569A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008CA2690567A1 New compounds
12/18/2008CA2688343A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008CA2688208A1 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
12/18/2008CA2687445A1 Process for preparing bepotastine and intermediates used therein
12/18/2008CA2685402A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008CA2684886A1 Dual-acting benzoimidazole antihypertensive agents
12/17/2008EP2003131A1 Aminopyrrolidine compound
12/17/2008EP2003130A2 Novel pyridine derivative having anti-helicobacter pylori activity
12/17/2008EP2003129A1 1H-Pyrido[3,4-B]indol-1-one and 2,3,4,9-Tetrahydro-1H-Beta-Carbolin-1-one Derivatives
12/17/2008EP2003119A1 Substituted acetamides as modulators of EP2 receptors
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2001875A2 Glucokinase activators
12/17/2008EP2001873A1 Active ingredient combinations with insecticidal properties
12/17/2008EP2001870A2 Kinase inhibitors
12/17/2008EP2001868A1 Inhibitors of the interaction between mdm2 and p53
12/17/2008EP2001867A2 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/17/2008EP2001866A2 Organic compounds
12/17/2008EP2001865A1 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
12/17/2008EP2001864A1 Heterocyclic organic compounds for the treatment of in particular melanoma
12/17/2008EP2001863A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
12/17/2008EP2001862A2 Malate salts, and polymorphs of (3s,5s)-7-ý3-amino-5-methyl-piperidinyl¨-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
12/17/2008EP2001855A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008EP2001849A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/17/2008EP2001848A1 Piperidines and related compounds for the treatment of dementia
12/17/2008EP2001478A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
12/17/2008EP2001474A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/17/2008EP2001472A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
1 ... 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 ... 1080